NKTR - Nektar Therapeutics Non-GAAP EPS of -$0.19 misses by $0.03 revenue of $24.1M beats by $2.79M
2023-11-07 16:19:10 ET
More on Nektar Therapeutics
- Nektar in collaboration to evaluate non-small cell lung cancer candidate
- Seeking Alpha’s Quant Rating on Nektar Therapeutics
- Historical earnings data for Nektar Therapeutics
- Financial information for Nektar Therapeutics
For further details see:
Nektar Therapeutics Non-GAAP EPS of -$0.19 misses by $0.03, revenue of $24.1M beats by $2.79M